207 related articles for article (PubMed ID: 29606309)
21. Cancer stem cells: recent developments and future prospects.
Singh SR
Cancer Lett; 2013 Sep; 338(1):1-2. PubMed ID: 23583678
[No Abstract] [Full Text] [Related]
22. The molecular composition of the metastatic niche.
Descot A; Oskarsson T
Exp Cell Res; 2013 Jul; 319(11):1679-86. PubMed ID: 23707205
[TBL] [Abstract][Full Text] [Related]
23. Mechanics: The forces of cancer.
Jonietz E
Nature; 2012 Nov; 491(7425):S56-7. PubMed ID: 23320288
[No Abstract] [Full Text] [Related]
24. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
25. Searching for the answer to cancer: new perspective may help to resolve an ageless conundrum.
Watson RA
Urol Oncol; 2013 Aug; 31(6):721-6. PubMed ID: 23769267
[No Abstract] [Full Text] [Related]
26. Targeting Tumor Physical Microenvironment for Improved Radiotherapy.
Wang J; Han Y; Li Y; Zhang F; Cai M; Zhang X; Chen J; Ji C; Ma J; Xu F
Small Methods; 2022 Nov; 6(11):e2200570. PubMed ID: 36116123
[TBL] [Abstract][Full Text] [Related]
27. Transport Oncophysics in silico, in vitro, and in vivo. Preface.
Koay EJ; Ferrari M
Phys Biol; 2014 Nov; 11(6):060201. PubMed ID: 25426742
[No Abstract] [Full Text] [Related]
28. Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.
Ebrahimi S; Ghorbani E; Khazaei M; Avan A; Ryzhikov M; Azadmanesh K; Hassanian SM
J Cell Biochem; 2017 Aug; 118(8):1994-1999. PubMed ID: 28135008
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic virotherapy.
Cervantes-García D; Ortiz-López R; Mayek-Pérez N; Rojas-Martínez A
Ann Hepatol; 2008; 7(1):34-45. PubMed ID: 18376364
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
Jung HY; Fattet L; Yang J
Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
[TBL] [Abstract][Full Text] [Related]
31. Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.
Giraldo NA; Peske JD; Sautès-Fridman C; Fridman WH
Virchows Arch; 2019 Apr; 474(4):463-474. PubMed ID: 30631935
[TBL] [Abstract][Full Text] [Related]
32. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
[TBL] [Abstract][Full Text] [Related]
33. Metastasis prevention by targeting the dormant niche.
Ghajar CM
Nat Rev Cancer; 2015 Apr; 15(4):238-47. PubMed ID: 25801619
[TBL] [Abstract][Full Text] [Related]
34. The many challenges of veterinary oncology.
Kidd C
Can Vet J; 2008 Nov; 49(11):1132-5. PubMed ID: 19183739
[No Abstract] [Full Text] [Related]
35. Targeted therapies in cancer: myth or reality? Introduction.
Colotta F; Mantovani A
Adv Exp Med Biol; 2008; 610():v-vi. PubMed ID: 18593010
[No Abstract] [Full Text] [Related]
36. Viruses in the treatment of malignant glioma.
Everson RG; Gromeier M; Sampson JH
Expert Rev Neurother; 2007 Apr; 7(4):321-4. PubMed ID: 17425484
[No Abstract] [Full Text] [Related]
37. Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy.
Puré E; Hingorani SR
Trends Cancer; 2018 Apr; 4(4):273-277. PubMed ID: 29606311
[TBL] [Abstract][Full Text] [Related]
38. Interventions that induce modifications in the tumor microenvironment.
Bernhard EJ
Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
[TBL] [Abstract][Full Text] [Related]
39. The role of the microenvironment in the biophysics of cancer.
Rianna C; Kumar P; Radmacher M
Semin Cell Dev Biol; 2018 Jan; 73():107-114. PubMed ID: 28746843
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix mechanobiology in cancer cell migration.
Vasudevan J; Jiang K; Fernandez JG; Lim CT
Acta Biomater; 2023 Jun; 163():351-364. PubMed ID: 36243367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
